NASDAQ:ONCS

OncoSec Medical - ONCS News Today

$1.93

-0.15 (-7.21%)

(As of 03/21/2023 12:00 AM ET)

Add

Compare

Today's Range: $1.90
▼
$2.13
50-Day Range: $1.01
▼
$2.89
52-Week Range: $0.74
▼
$31.90

Volume: 252,237 shs
Average Volume: 2.40 million shs
Market Capitalization: $5.73 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

Get OncoSec Medical News Delivered to You Automatically

ONCS Media Mentions By Week

ONCS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ONCS
News Sentiment
▼
0.00

0.34
▲
Average
Medical
News Sentiment

ONCS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ONCS Articles
This Week
▼
1

0
▲
ONCS Articles
Average Week

Source

Source	Headline
	OncoSec Medical Withdraws Planned Offering, Shares Rise Over 50% marketwatch.com - March 1 at 8:56 AM
	Why is OncoSec Medical (ONCS) Stock Up 91% Today? msn.com - March 1 at 8:56 AM
	ONCS.OQ - \| Stock Price & Latest News \| Reuters reuters.com - January 16 at 7:08 PM
	OncoSec Medical Stock (NASDAQ:ONCS), Quotes and News Summary benzinga.com - January 5 at 3:51 PM
	Peering Into OncoSec Medical's Recent Short Interest msn.com - December 8 at 5:34 PM
	OncoSec to Present at the RHK Capital Disruptive Growth Conference on December 6, 2022 finance.yahoo.com - December 5 at 1:28 PM
	OncoSec Shares Drop 25% on Equity Offer Pricing After 51% Tuesday Surge marketwatch.com - November 30 at 5:53 PM
	OncoSec Announces Pricing of $3.5 Million Public Offering finance.yahoo.com - November 30 at 12:53 PM
	OncoSec Touts Encouraging Early Data For Opdivo Combined Immunotherapy For Skin Cancer finance.yahoo.com - November 24 at 8:52 AM
	OncoSec provides updates on cancer programs in new filing seekingalpha.com - November 23 at 4:19 PM
	Looking Into OncoSec Medical's Recent Short Interest msn.com - November 22 at 5:01 PM
	OncoSec presents encouraging early data with TAVO™-EP combined with nivolumab (Opdivo®) in neoadjuvant melanoma finance.yahoo.com - November 15 at 9:33 PM
	OncoSec Announces Positive Clinical Data of the KEYNOTE-695 Trial Assessing TAVO-EP in Combination with Pembrolizumab (Keytruda®) in Patients with Advanced Melanoma Refractory to anti-PD-1 Treatment finance.yahoo.com - November 11 at 2:56 PM
	OncoSec Medical Shares Hit New Depths Ahead of Reverse Stock Split >ONCS marketwatch.com - November 8 at 4:49 PM
	OncoSec Announces Reverse Stock Split finance.yahoo.com - November 8 at 4:49 PM
	OncoSec Cuts Workforce, Prioritizes Pipeline finance.yahoo.com - October 13 at 4:36 AM
	OncoSec Medical to Restructure, Cut Jobs marketwatch.com - October 4 at 10:56 PM
	OncoSec Medical To Reduce Staff By About 45% markets.businessinsider.com - October 4 at 10:56 PM
	OncoSec Announces Pipeline Prioritization and Workforce Reduction finance.yahoo.com - October 4 at 5:55 PM
	Robert Arch joins OncoSec Medical as CEO seekingalpha.com - April 29 at 12:39 PM
	OncoSec Appoints Dr. Robert Arch as President and Chief Executive Officer finance.yahoo.com - April 29 at 12:39 PM
	BTIG Maintains Buy on OncoSec Medical, Lowers Price Target to $5 benzinga.com - March 16 at 11:40 AM
	OncoSec appoints new finance chief seekingalpha.com - February 23 at 6:32 AM
	OncoSec Medical Inc Shares Approach 52-Week Low - Market Mover nasdaq.com - October 9 at 3:12 AM
	OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference finance.yahoo.com - August 3 at 9:00 AM
	OncoSec Medical Incorporated Common Stock (ONCS) nasdaq.com - July 27 at 11:20 PM
	OncoSec Hikes on Start of Clinical Trial marketwatch.com - July 7 at 1:14 PM
	Why Shares Of OncoSec Medical Are Trading Higher Today benzinga.com - July 7 at 1:14 PM
	OncoSec Stock Jumps On Anti-Cancer Gene Therapy Trial Collaboration With Merck In Melanoma finance.yahoo.com - July 7 at 1:14 PM
	OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of TAVO™ Combined with KEYTRUDA® for Late-Stage Metastatic Melanoma finance.yahoo.com - July 6 at 7:48 PM
	OncoSec Appoints Brian Leuthner as Interim Chief Executive Officer finance.yahoo.com - June 24 at 5:39 PM
	OncoSec Appoints Industry Leading Electroporation Device Expert, Jeffrey Silverman, as Vice President of Product Engineering finance.yahoo.com - June 14 at 8:34 AM
	OncoSec to Present at the Raymond James Human Health Innovation Conference finance.yahoo.com - May 27 at 9:06 AM
	OncoSec Aims to Treat Cancer with what the Body Makes Naturally — IL-12 benzinga.com - May 3 at 12:53 PM
	How Much Of OncoSec Medical Incorporated (NASDAQ:ONCS) Do Institutions Own? nasdaq.com - April 29 at 3:26 PM
	OncoSec receives CE mark certification for its commercial electroporation device seekingalpha.com - April 16 at 9:24 AM
	OncoSec to Present Encore Interim Data from the KEYNOTE-695 Phase 2b Clinical Trial at the 10th World Congress of Melanoma finance.yahoo.com - April 15 at 1:28 PM
	OncoSec Receives CE Mark Certification for its Commercial Electroporation Device "GenPulse™" for the Treatment of Solid Tumors finance.yahoo.com - April 14 at 10:34 AM
	OncoSec Medical Sponsoring KOL Webinar On A High Unmet Medical Need: Anti-PD-1 Checkpoint Refractory Metastatic Melanoma finance.yahoo.com - April 2 at 8:25 AM
	OncoSec Announces Publication in Clinical Cancer Research of Data Supporting the Therapeutic Potential of Lead Product Candidate, TAVO™, in Triple Negative Breast Cancer finance.yahoo.com - March 1 at 10:28 AM
	OncoSec Announces Approval of $2.5 Million in NJEDA NOL Program Tax Benefits finance.yahoo.com - February 23 at 12:35 PM
	OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development finance.yahoo.com - February 18 at 10:13 AM
	What Type Of Shareholders Own The Most Number of OncoSec Medical Incorporated (NASDAQ:ONCS) Shares? finance.yahoo.com - February 2 at 2:53 PM
	OncoSec Strengthens Management Team With Two New Appointments finance.yahoo.com - February 2 at 2:53 PM
	OncoSec Announces First Subjects Dosed in Phase 1 Trial of CORVax12, OncoSec's COVID-19 Vaccine Candidate Combining Interleukin-12 (IL-12) with an Enhanced SARS-CoV-2 Spike Protein finance.yahoo.com - January 27 at 9:15 AM
	OncoSec Medical Closes $42.0 Million Public Offering of Common Stock finance.yahoo.com - January 25 at 7:08 PM
	OncoSec Medical Announces Pricing of $42.0 Million Public Offering of Common Stock finance.yahoo.com - January 21 at 9:46 AM
	OncoSec Medical Announces Proposed Public Offering of Common Stock finance.yahoo.com - January 20 at 8:47 PM
	OncoSec Enters into Option Agreement with Sirtex Medical to Co-Promote TAVO™ finance.yahoo.com - January 19 at 1:45 PM
	Sirtex Medical announces collaboration update with OncoSec Medical finance.yahoo.com - January 19 at 1:45 PM

Get OncoSec Medical News Delivered to You Automatically

This page (NASDAQ:ONCS) was last updated on 3/21/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

OncoSec Medical - ONCS News Today

ONCS Media Mentions By Week

ONCS Media Sentiment

ONCS News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info